Healthtech Series C Investors & VC Firms

771 firms in this list, with a median first check of $1M. 164 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
EX Excel Venture Management CWJERBSG8 people	88🔒	Boston	US	Seed–Late Stage	$1M – $5M	+ Add to CRM
MI Miyako Capital 三宏山哲菅常川英5 people	88🔒	Kyoto	JP	Pre-Seed–Growth	—	+ Add to CRM
HM HM Venture Partners RLDHHHPL7 people · Leads rounds	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
MU Mutual Capital Partners LTWBBTWW4 people	88🔒	Cleveland	US	Seed–Late Stage	$1M	+ Add to CRM
AM Amador Holdings AGGCJIRS6 people	88🔒	Panama City	PA	Seed–Growth	—	+ Add to CRM
EL Ellerston Capital AJCKDKMP18 people	88🔒	Sydney	AU	Series A–Late Stage	—	+ Add to CRM
HI Highline Beta MDBYDBJM18 people	88🔒	Toronto	CA	Pre-Seed–Growth	—	+ Add to CRM
EI EIR Ventures AHMPSCLB10 people · Leads rounds	88🔒	Stockholm	SE	Seed–Growth	—	+ Add to CRM
RE Red River West AVABLBOH7 people · Leads rounds	88🔒	Paris, Ile-De-France	FR	Seed–Growth	$5.4M – $54M	+ Add to CRM
SE Seiho Investment Works 関兵菅靖岡友根大7 people	88🔒	Kyoto	JP	Pre-Seed–Growth	$67K – $670K	+ Add to CRM
EQ Equitage Ventures, L.L.C. AKRHDSDK9 people	88🔒	Denver	US	Pre-Seed–Late Stage	$250K – $2.5M	+ Add to CRM
JA Japan startup support Association	88🔒	Osaka	JP	Pre-Seed–Growth	—	+ Add to CRM
BI Bios Partners LWAGADJF15 people	88🔒	Fort Worth	US	Seed–Growth	—	+ Add to CRM
TB TBT	88🔒	Seoul	KR	Pre-Seed–Late Stage	—	+ Add to CRM
CV CVC Asia Pacific (Japan) Kabushiki Kaisha AAAACHGA11 people	88🔒	Tokyo	JP	Series B–Late Stage	—	+ Add to CRM
NE Neulogy Ventures CMJLDSMS5 people	88🔒	Luxembourg	LU	Pre-Seed–Growth	$216K – $3.2M	+ Add to CRM
PU Pureos Bioventures DEKBMMVG11 people	88🔒	Pfäffikon	CH	Seed–Series C	—	+ Add to CRM
FE FEMSA Ventures JG1 person	88🔒	Mexico City	MX	Seed–Growth	$500K – $5M	+ Add to CRM
CR Criteria Bio Ventures PCACSCSC8 people · Leads rounds	88🔒	Barcelona	ES	Seed–Late Stage	—	+ Add to CRM
DU Dubai Future District Fund HOAAAEHA17 people · Follows rounds	88🔒	Dubai	AE	Pre-Seed–Late Stage	—	+ Add to CRM
SO Solasta Ventures MJBCDYKG8 people	88🔒	Boston	US	Seed–Series C	—	+ Add to CRM
UN Union Grove Venture Partners GBPC2 people	88🔒	Chapel Hill	US	Pre-Seed–Late Stage	—	+ Add to CRM
AP APERTURE Venture Partners ANESPTTC4 people	88🔒	Boston	US	Seed–Series C	$1M – $5M	+ Add to CRM
RO Rocket Internet SE OSDAGJSM10 people	88🔒	Berlin	DE	Seed–Late Stage	—	+ Add to CRM

Excel Venture Management

BostonSeed–Late Stage$1M – $5M

CWJERBSG8 people

Miyako Capital

KyotoPre-Seed–Growth

三宏山哲菅常川英5 people

HM Venture Partners

San FranciscoSeed–Late Stage

RLDHHHPL7 people

Mutual Capital Partners

ClevelandSeed–Late Stage$1M

LTWBBTWW4 people

Amador Holdings

Panama CitySeed–Growth

AGGCJIRS6 people

Ellerston Capital

SydneySeries A–Late Stage

AJCKDKMP18 people

Highline Beta

TorontoPre-Seed–Growth

MDBYDBJM18 people

EIR Ventures

StockholmSeed–Growth

AHMPSCLB10 people

Red River West

Paris, Ile-De-FranceSeed–Growth$5.4M – $54M

AVABLBOH7 people

Seiho Investment Works

KyotoPre-Seed–Growth$67K – $670K

関兵菅靖岡友根大7 people

Equitage Ventures, L.L.C.

DenverPre-Seed–Late Stage$250K – $2.5M

AKRHDSDK9 people

Japan startup support Association

OsakaPre-Seed–Growth

Bios Partners

Fort WorthSeed–Growth

LWAGADJF15 people

TBT

SeoulPre-Seed–Late Stage

CVC Asia Pacific (Japan) Kabushiki Kaisha

TokyoSeries B–Late Stage

AAAACHGA11 people

Neulogy Ventures

LuxembourgPre-Seed–Growth$216K – $3.2M

CMJLDSMS5 people

Pureos Bioventures

PfäffikonSeed–Series C

DEKBMMVG11 people

FEMSA Ventures

Mexico CitySeed–Growth$500K – $5M

JG1 person

Criteria Bio Ventures

BarcelonaSeed–Late Stage

PCACSCSC8 people

Dubai Future District Fund

DubaiPre-Seed–Late Stage

HOAAAEHA17 people

Solasta Ventures

BostonSeed–Series C

MJBCDYKG8 people

Union Grove Venture Partners

Chapel HillPre-Seed–Late Stage

GBPC2 people

APERTURE Venture Partners

BostonSeed–Series C$1M – $5M

ANESPTTC4 people

Rocket Internet SE

BerlinSeed–Late Stage

OSDAGJSM10 people

Data sourced from public filings and firms' own websites — see our methodology.